DR. NORMAN EDWARD ROSENTHAL, MD
Psychiatric at Stephalee Ln, Rockville, MD

2001003, Nov 1, 2001

Apr 20, 2001

09/838263

Norman Rosenthal - Rockville MD, US
Richard Friedman - New York NY, US

A61K035/78

424/730000, 424/734000, 424/737000, 424/733000, 424/778000

A method of treating nicotine addiction or deterring tobacco use in a subject by administering to the subject a therapeutically effective amount of or at least one active component thereof is disclosed. As disclosed, the composition may further comprise a pharmaceutically acceptable carrier. The composition may also comprise a supplementary compound such as L-phenylalanine, L-tyrosine, tryptophan, 5-hydroxy tryptamine, serotonin, calcium carbonate and magnesium oxide, kava-kava, a kava alkaloid, valerian, hops, a passion flower extract, vitamin C, or Echinacea.

4911166, Mar 27, 1990

Mar 6, 1989

7/319243

Stephen B. Leighton - Maplewood NJ
Norman E. Rosenthal - Rockville MD
Thomas A. Wehr - Bethesda MD

The United States of America as represented by the Department of Health
and Human Services - Washington DC

A61N 506

128380

A device for delivering high intensity light to a patient's eyes for treating seasonal affective disorder and the like uses a point source of light such as a high intensity halogen or other incandescent bulb, and directs a large fraction of the light from the bulb directly into the patient's eyes without focusing the light in such a way as to cause damage to the eye or discomfort to the patient. This is accomplished by the use of a positive lens which focuses the light from the high intensity bulb directly in front of the patient's eyes. The light appears to the patient to be coming from an area much larger than the actual point source, and hence is more comfortable for the patient. The patient is assured of receiving a significant dosage of light no matter which way he is directing his gaze.